| Rebecca Paustian, | |
|
210 Ravine Dr, Matawan, NJ 07747-2843 | |
| (732) 547-1194 | |
| Not Available |
| Full Name | Rebecca Paustian |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 7 Years |
| Location | 210 Ravine Dr, Matawan, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720524630 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Barnabas Medical Center | Livingston, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rwjbh Observation Associates Llc | 5193137503 | 598 |
News Archive
Celsion Corporation, a leading oncology drug development company, today announced that ThermoDox in combination with radiofrequency ablation (RFA) did not meet the primary endpoint of the Phase III HEAT Study in patients with hepatocellular carcinoma (HCC), also known as primary liver cancer.
Capario, a leading provider of revenue cycle management solutions that connect healthcare payers and providers nationwide, today announced it has achieved the CAQH® Committee on Operating Rules for Information Exchange (CORE®) Phase II Certification for its Phoenix Processing System.
Combining certain types of two antipsychotic agents in the maintenance treatment of schizophrenia is associated with a lower risk of relapse than using monotherapy. T
An exhaustive review - the first in almost a decade, including the latest evidence on the health effects of silicone breast implants - finds no increase in the risk of cancers, connective tissue diseases, or other serious chronic diseases.
› Verified 5 days ago
| Entity Name | American Anesthesiology Of New Jersey Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386654036 PECOS PAC ID: 0042112500 Enrollment ID: O20040123001039 |
News Archive
Celsion Corporation, a leading oncology drug development company, today announced that ThermoDox in combination with radiofrequency ablation (RFA) did not meet the primary endpoint of the Phase III HEAT Study in patients with hepatocellular carcinoma (HCC), also known as primary liver cancer.
Capario, a leading provider of revenue cycle management solutions that connect healthcare payers and providers nationwide, today announced it has achieved the CAQH® Committee on Operating Rules for Information Exchange (CORE®) Phase II Certification for its Phoenix Processing System.
Combining certain types of two antipsychotic agents in the maintenance treatment of schizophrenia is associated with a lower risk of relapse than using monotherapy. T
An exhaustive review - the first in almost a decade, including the latest evidence on the health effects of silicone breast implants - finds no increase in the risk of cancers, connective tissue diseases, or other serious chronic diseases.
› Verified 5 days ago
| Entity Name | North American Partners In Anesthesia Of New Jersey Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548433048 PECOS PAC ID: 5890867410 Enrollment ID: O20080626000318 |
News Archive
Celsion Corporation, a leading oncology drug development company, today announced that ThermoDox in combination with radiofrequency ablation (RFA) did not meet the primary endpoint of the Phase III HEAT Study in patients with hepatocellular carcinoma (HCC), also known as primary liver cancer.
Capario, a leading provider of revenue cycle management solutions that connect healthcare payers and providers nationwide, today announced it has achieved the CAQH® Committee on Operating Rules for Information Exchange (CORE®) Phase II Certification for its Phoenix Processing System.
Combining certain types of two antipsychotic agents in the maintenance treatment of schizophrenia is associated with a lower risk of relapse than using monotherapy. T
An exhaustive review - the first in almost a decade, including the latest evidence on the health effects of silicone breast implants - finds no increase in the risk of cancers, connective tissue diseases, or other serious chronic diseases.
› Verified 5 days ago
| Entity Name | Rwjbh Observation Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760095806 PECOS PAC ID: 5193137503 Enrollment ID: O20201209000008 |
News Archive
Celsion Corporation, a leading oncology drug development company, today announced that ThermoDox in combination with radiofrequency ablation (RFA) did not meet the primary endpoint of the Phase III HEAT Study in patients with hepatocellular carcinoma (HCC), also known as primary liver cancer.
Capario, a leading provider of revenue cycle management solutions that connect healthcare payers and providers nationwide, today announced it has achieved the CAQH® Committee on Operating Rules for Information Exchange (CORE®) Phase II Certification for its Phoenix Processing System.
Combining certain types of two antipsychotic agents in the maintenance treatment of schizophrenia is associated with a lower risk of relapse than using monotherapy. T
An exhaustive review - the first in almost a decade, including the latest evidence on the health effects of silicone breast implants - finds no increase in the risk of cancers, connective tissue diseases, or other serious chronic diseases.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rebecca Paustian, 210 Ravine Dr, Matawan, NJ 07747-2843 Ph: (732) 547-1194 | Rebecca Paustian, 210 Ravine Dr, Matawan, NJ 07747-2843 Ph: (732) 547-1194 |
News Archive
Celsion Corporation, a leading oncology drug development company, today announced that ThermoDox in combination with radiofrequency ablation (RFA) did not meet the primary endpoint of the Phase III HEAT Study in patients with hepatocellular carcinoma (HCC), also known as primary liver cancer.
Capario, a leading provider of revenue cycle management solutions that connect healthcare payers and providers nationwide, today announced it has achieved the CAQH® Committee on Operating Rules for Information Exchange (CORE®) Phase II Certification for its Phoenix Processing System.
Combining certain types of two antipsychotic agents in the maintenance treatment of schizophrenia is associated with a lower risk of relapse than using monotherapy. T
An exhaustive review - the first in almost a decade, including the latest evidence on the health effects of silicone breast implants - finds no increase in the risk of cancers, connective tissue diseases, or other serious chronic diseases.
› Verified 5 days ago